Minireview: Estrogen and mouse models of atherosclerosis

Endocrinology

Volumn 143, Issue 12, 2002, Pages 4495-4501

  Hodgin, Jeffrey B ^a   Maeda, Nobuyo ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LOW DENSITY LIPOPROTEIN RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; HORMONE SUBSTITUTION; INHIBITION KINETICS; LIPID OXIDATION; MODULATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK ASSESSMENT; SHORT SURVEY;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, ESTROGEN; RECEPTORS, LDL;

EID: 0036892157     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220844     Document Type: Short Survey

References (62)

1. Ross R 1999 Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126
2. Mosca L 1998 Estrogen and atherosclerosis. J Investig Med 46: 381-386
3. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR 1992 Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016-1037
4. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613
5. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D 2000 Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343: 522-529
6. Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333
7. The Writing Group for the PEPI Trial 1995 Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273: 199-208
8. Adams MR, Register TC, Golden DL, Wagner JD, Williams JK 1997 Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 17: 217-221
9. Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Seizer RH, Liu Cr C, Liu Ch C, Azen SP 2001 Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 135: 939-953
10. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811
11. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA 1997 Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 95: 39-45
12. Giltay EJ, Gooren LJ, Emeis JJ, Kooistra T, Stehouwer CD 2000 Oral ethinyl estradiol, but not transdermal 17β-estradiol, increases plasma C-reactive protein levels in men. Thromb Haemost 84: 359-360
13. Ross R 1995 Cell biology of atherosclerosis. Annu Rev Physiol 57: 791-804
14. Holm P 2001 Effect of estrogen on development of atherosclerosis. A review of experimental animal studies. Dan Med Bull 48: 146-160
15. Knowles JW, Maeda N 2000 Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 2336-2345
16. Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ, Chaudhuri G 2001 Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase. Proc Natl Acad Sci USA 98: 3589-3593
17. Tse J, Martin-McNaulty B, Halks-Miller M, Kauser K, DelVecchio V, Vergona R, Sullivan ME, Rubanyi GM 1999 Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17β-estradiol. Atherosclerosis 144: 303-313
18. Haarbo J, Leth-Espensen P, Stender S, Christiansen C 1991 Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 87: 1274-1279
19. Bjarnason NH, Haarbo J, Byrjalsen I, Kauffman RF, Christiansen C 1997 Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits. Circulation 96: 1964-1969
20. Buko VU, Lukivskaya O, Naruta E, Popov Y, Chirkin A, Chirkina I, Oettel M, Romer W, Hubler D 2001 Antiatherogenic effects of 17β-estradiol and 17α-estradiol and its derivative J811 in cholesterol-fed rabbits with thyroid inhibition. Climacteric 4: 49-57
21. Williams JK, Adams MR, Klopfenstein HS 1990 Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81: 1680-1687
22. Sulistiyani, Adelman SJ, Chandrasekaran A, Jayo J, St Clair RW 1995 Effect of 17α-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 15: 837-846
23. Hanke H, Hanke S, Finking G, Muhic-Lohrer A, Muck AO, Schmahl FW, Haasis R, Hombach V 1996 Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromodeoxyuridine. Circulation 94: 175-181
24. Haines CJ, James AE, Panesar NS, Ngai TJ, Sahota DS, Jones RL, Chang AM 1999 The effect of percutaneous oestradiol on atheroma formation in ovariectomized cholesterol-fed rabbits. Atherosclerosis 143: 369-375
25. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB 1990 Inhibition of coronary artery atherosclerosis by 17β estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 10: 1051-1057
26. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR 1991 Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 88: 1995-2002
27. Wagner JD, Schwenke DC, Zhang L, Applebaum-Bowden D, Bagdade JD, Adams MR 1997 Effects of short-term hormone replacement therapies on low-density lipoprotein metabolism in cynomologus monkeys. Arterioscler Thromb Vasc Biol 17: 1128-1134
28. Elhage R, Arnal JF, Pieraggi MT, Duverger N, Fievet C, Faye JC, Bayard F 1997 17β-Estradiol prevents fatty streak formation in apolipoprotein E- deficient mice. Arterioscler Thromb Vasc Biol 17: 2679-2684
29. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ 1996 Estrogen reduces atherosclerotic lesion development in apolipoprotein E- deficient mice. Proc Natl Acad Sci USA 93: 10022-10027
30. Marsh MM, Walker VR, Curtiss LK, Banka CL 1999 Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 40: 893-900
31. Zuckerman SH, Evans GF, Schelm JA, Eacho PI, Sandusky G 1999 Estrogen-mediated increases in LDL cholesterol and foam cell-containing lesions in human ApoB100xCETP transgenic mice. Arterioscler Thromb Vasc Biol 19: 1476-1483
32. Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M, Chambon P 1985 Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 82: 7889-7893
33. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930
34. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90: 11162-11166
35. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M 2000 Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development 127: 4277-4291
36. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci USA 95: 15677-15682
37. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N 2001 Estrogen receptor α is a major mediator of 17β-estradiol's atheroprotective effects on lesion size in Apoe(-/-) mice. J Clin Invest 107: 333-340
38. Pettersson K, Grandien K, Kuiper GG, Gustafsson JA 1997 Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 11: 1486-1496
39. Pendaries C, Darblade B, Rochaix P, Krust A, Chambon P, Korach KS, Bayard F, Arnal JF 2002 The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 99: 2205-2210
40. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, Gustafsson JA, Korach KS, Smithies O, Mendelsohn ME 1999 Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci USA 96: 15133-15136
41. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan Jr TR, Lubahn DB, O'Donnell Jr TF, Korach KS, Mendelsohn ME 1997 Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat Med 3: 545-548
42. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, Mendelsohn ME 2002 Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res 90: 1087-1092
43. Kuhel DG, Zhu B, Witte DP, Hui DY 2002 Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice. Arterioscler Thromb Vasc Biol 22: 955-960
44. Moncada S, Higgs A 1993 The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012
45. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N 2000 Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 105: 451-458
46. Hodgin JB, Knowles JW, Kim HS, Smithies O, Maeda N 2002 Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice. J Clin Invest 109: 541-548
47. Elhage R, Bayard F, Richard V, Holvoet P, Duverger N, Fievet C, Arnal JF 1997 Prevention of fatty streak formation of 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 96: 3048-3052
48. Elhage R, Clamens S, Reardon-Alulis C, Getz GS, Fievet C, Maret A, Arnal JF, Bayard F 2000 Loss of atheroprotective effect of estradiol in immunodeficient mice. Endocrinology 141: 462-465
49. Elhage R, Clamens S, Besnard S, Mallat Z, Tedgui A, Arnal J, Maret A, Bayard F 2001 Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 156: 315-320
50. Sack MN, Rader DJ, Cannon 3rd RO 1994 Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343: 269-270
51. Caulin-Glaser T, Watson CA, Pardi R, Bender JR 1996 Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98: 36-42
52. Frazier-Jessen MR, Kovacs EJ 1995 Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol 154: 1838-1845
53. St Clair RW 1997 Effects of estrogens on macrophage foam cells: A potential target for the protective effects of estrogens on atherosclerosis. Curr Opin Lipidol 8: 281-286
54. Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Stablein A, Beckers F, Smits JF, Daemen MJ, Vetter H, Bohm M 1998 Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-201
55. Mikkola T, Viinikka L, Ylikorkala O 1998 Estrogen and postmenopausal estrogen/progestin therapy: Effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production. Eur J Obstet Gynecol Reprod Biol 79: 75-82
56. Williams JK, Anthony MS, Honore EK, Herrington DM, Morgan TM, Register TC, Clarkson TB 1995 Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol 15: 827-836
57. Clarkson TB, Anthony MS, Morgan TM 2001 Inhibition of postmenopausal atherosclerosis progression: A comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 86: 41-47
58. Bjarnason NH, Haarbo J, Byrjalsen I, Alexandersen P, Kauffman RF, Christiansen C 2001 Raloxifene and estrogen reduces progression of advanced atherosclerosis - A study in ovariectomized, cholesterol-fed rabbits. Atherosclerosis 154: 97-102
59. Hanke H, Kamenz J, Hanke S, Spiess J, Lenz C, Brehme U, Bruck B, Finking G, Hombach V 1999 Effect of 17-β estradiol on pre-existing atherosclerotic lesions: Role of the endothelium. Atherosclerosis 147: 123-132
60. Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, Rautaharju P, Harper KD 2002 Raloxifene and cardiovascular events in osteoporotic postmenopausal women: Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 287: 847-857
61. Adams MR, Anthony MS, Manning JM, Golden DL, Parks JS 2000 Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys. Obstet Gynecol 96: 250-255
62. Clarkson TB, Anthony MS, Jerome CP 1998 Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys. J Clin Endocrinol Metab 83: 721-726